Biologics Quality Control Testing
PathoQuest, a spin-out of Institut Pasteur Paris, is a genomics expert company offering a game-changing next-generation sequencing (NGS) approach for microbiology testing.
The NGS-based technology the company has developed is used for:
• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GLP and GMP level
PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.
Access Today’s Innovative Scientific Data, Technologies, and Collaborations to Improve Efficiencies and Ensure Quality Across All Phases of Bioprocessing.
PathoQuest in BioPharma Asia webinar: CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy
🧬Advanced gene therapy development programs require innovative paths to reach licensure promptly ⏱
This Thursday 23rd March 2022 | 10:00am EST / 2:00pm GMT / 3:00pm CET | learn more on those applications and how #NGS fits into it with @biopharma Asia webinar 💻presented by @Sarah Thomas, from @REGENXBIO Inc. and followed by @Joanna Zmurko from @pathoquest
CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy
PathoQuest participates in the Next-Generation CAR-TCR European Event, a unique opportunity to connect with our team and understand how NGS could benefit your advanced therapies production.
Let’s Start Something New
Welcome to PathoQuest!